Lanke Elsa, Kristoffersson Ann-Charlotte, Philips Malou, Holmberg Lars, Lethagen Stefan
Department for Coagulation Disorders, University Hospital, Malmö, Sweden.
Thromb Haemost. 2008 Aug;100(2):211-6.
von Willebrand factor (VWF) is a plasma protein that consists of a series of multimers of which the high-molecular-weight VWF multimers are the most potent in platelet adhesion and aggregation. The propeptide of the VWF (VWFpp) is known to be essential in the process of multimer assembly. Genetic studies were performed in a patient with a phenotype of von Willebrand disease (VWD) characterized by very low plasma factor VIII and VWF levels and a VWF consisting of only a dimeric band and total absence of all multimers in plasma. The patient was found to be homozygous for the novel C570S mutation, caused by a 1709G>C transition in exon 14 of the VWF gene coding for the propeptide. Three asymptomatic relatives were found to be heterozygous. In-vitro mutagenesis and expression in COS-7 cells confirmed the detrimental effect of the mutation on VWF multimerization. Our findings show that the C570S mutation in the VWFpp abolishes multimerization of VWF. The mutation probably disrupts the normal configuration of the VWFpp, which is essential for correct orientation of the protomers and ultimately multimerization. The mutant amino acid is located in a region that is highly conserved across several species which underlines its critical role. This variant constitutes a distinct subtype of recessive 2A VWD with the exclusive presence of the dimeric form of VWF in plasma.
血管性血友病因子(VWF)是一种血浆蛋白,由一系列多聚体组成,其中高分子量的VWF多聚体在血小板黏附和聚集方面最为有效。已知VWF的前肽(VWFpp)在多聚体组装过程中至关重要。对一名血管性血友病(VWD)患者进行了基因研究,该患者的特征是血浆因子VIII和VWF水平极低,血浆中的VWF仅由一条二聚体条带组成,且完全没有所有多聚体。发现该患者对于由VWF基因编码前肽的第14外显子中的1709G>C转换引起的新型C570S突变是纯合的。发现三名无症状亲属为杂合子。体外诱变和在COS-7细胞中的表达证实了该突变对VWF多聚化的有害影响。我们的研究结果表明,VWFpp中的C570S突变消除了VWF的多聚化。该突变可能破坏了VWFpp的正常构型,这对于原聚体的正确定向以及最终的多聚化至关重要。突变氨基酸位于多个物种中高度保守的区域,这突出了其关键作用。这种变异构成了隐性2A VWD的一种独特亚型,血浆中仅存在VWF的二聚体形式。